|
Quotes & Info
|
| NBY > SEC Filings for NBY > Form 8-K on 14-Jan-2009 | All Recent SEC Filings |
14-Jan-2009
Change in Directors or Principal Officers
NovaBay Pharmaceuticals Inc is reporting that effective at the close of business on January 8, 2009, John (Jack) James O'Reilly resigned from his position as Member of the Board of Directors. Mr. O'Reilly's decision to resign was the result of hearing loss that has been increasingly preventing him from playing a full role within the company.
|
|